119 related articles for article (PubMed ID: 2327116)
1. Transition from Lanoxin capsules to Lanoxin tablets in the debilitated elderly.
Drinka PJ; Nickel DA; Schomisch GW; Depka CH; Deterville RJ
DICP; 1990 Apr; 24(4):381-2. PubMed ID: 2327116
[TBL] [Abstract][Full Text] [Related]
2. Comparison of steady-state serum concentrations of digoxin in tablets (Lanoxin) and capsules (Lanoxicaps) in the elderly.
Pouwels MJ; Hooymans PM; van der Aa GC; Gribnau FW
DICP; 1991 Oct; 25(10):1043-6. PubMed ID: 1803786
[TBL] [Abstract][Full Text] [Related]
3. Absorption of digoxin from tablets and capsules in subjects with malabsorption syndromes.
Heizer WD; Pittman AW; Hammond JE; Fitch DD; Bustrack JA; Hull JH
DICP; 1989 Oct; 23(10):764-9. PubMed ID: 2815851
[TBL] [Abstract][Full Text] [Related]
4. The comparability of dosage regimens of Lanoxin tablets and Lanoxicaps.
Johnson BF; Smith G; French J
Br J Clin Pharmacol; 1977 Apr; 4(2):209-11. PubMed ID: 861135
[TBL] [Abstract][Full Text] [Related]
5. The comparative bioavailability of Lanoxin tablets and Lanoxicaps with and without sorbitol.
O'Grady J; Johnson BF; Bye C; French J
Eur J Clin Pharmacol; 1978 Dec; 14(5):357-60. PubMed ID: 729628
[TBL] [Abstract][Full Text] [Related]
6. Digoxin bioavailability: formulations and rates of infusions.
Marcus FI; Dickerson J; Pippin S; Stafford M; Bressler R
Clin Pharmacol Ther; 1976 Sep; 20(3):253-9. PubMed ID: 954346
[TBL] [Abstract][Full Text] [Related]
7. Biological availability of digoxin from Lanoxin produced in the United Kingdom.
Johnson BF; Fowle AS; Lader S; Fox J; Munro-Faure AD
Br Med J; 1973 Nov; 4(5888):323-6. PubMed ID: 4758424
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability studies with Digoxin-Sandoz and Lanoxin.
Beveridge T; Kalberer F; Nüesch E; Schmidt R
Eur J Clin Pharmacol; 1975 Jun; 8(5):371-6. PubMed ID: 1243983
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of the absorption, plasma levels, and urinary excretion of the "new" and the "old" Lanoxin.
Falch D; Teien A; Bjerkelund CJ
Br Med J; 1973 Mar; 1(5855):695-7. PubMed ID: 4694690
[TBL] [Abstract][Full Text] [Related]
10. Effects of high-dose cancer chemotherapy on the absorption of digoxin in two different formulations.
Bjornsson TD; Huang AT; Roth P; Jacob DS; Christenson R
Clin Pharmacol Ther; 1986 Jan; 39(1):25-8. PubMed ID: 3943266
[TBL] [Abstract][Full Text] [Related]
11. Disposition of tablet and capsule formulations of digoxin in the elderly.
Hui J; Wang YM; Chandrasekaran A; Geraets DR; Caldwell JH; Robertson LW; Reuning RH
Pharmacotherapy; 1994; 14(5):607-12. PubMed ID: 7997395
[TBL] [Abstract][Full Text] [Related]
12. Digoxin prescribing in general practice 1967--77.
Pedoe HD
Lancet; 1978 Oct; 2(8096):931-3. PubMed ID: 81940
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the bioavailability of digoxin in capsule, tablet, and solution taken orally with intravenous digoxin.
Binnion PF
J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):461-7. PubMed ID: 977789
[TBL] [Abstract][Full Text] [Related]
14. Variability of steady-state digoxin kinetics during administration of tablets or capsules.
Johnson BF; Lindenbaum J; Budnitz E; Marwaha R
Clin Pharmacol Ther; 1986 Mar; 39(3):306-12. PubMed ID: 3948469
[TBL] [Abstract][Full Text] [Related]
15. A steady-state evaluation of the effects of propantheline bromide and cholestyramine on the bioavailability of digoxin when administered as tablets or capsules.
Brown DD; Schmid J; Long RA; Hull JH
J Clin Pharmacol; 1985; 25(5):360-4. PubMed ID: 4031112
[TBL] [Abstract][Full Text] [Related]
16. A completely absorbed oral preparation of digoxin.
Johnson BF; Bye C; Jones G; Sabey GA
Clin Pharmacol Ther; 1976 Jun; 19(6):746-51. PubMed ID: 1269214
[TBL] [Abstract][Full Text] [Related]
17. Superior bioavailability of digoxin solution in capsules.
Mallis GI; Schmidt DH; Lindenbaum J
Clin Pharmacol Ther; 1975 Dec; 18(6):761-8. PubMed ID: 1106935
[TBL] [Abstract][Full Text] [Related]
18. Maximal bioavailability of digoxin from tablets and oral solution in steady state.
Manninen V; Reissell P; Ojala K
Acta Med Scand; 1976; 199(6):487-9. PubMed ID: 937075
[TBL] [Abstract][Full Text] [Related]
19. Decreased digoxin cardioinactive-reduced metabolites after administration as an encapsulated liquid concentrate.
Rund DG; Lindenbaum J; Dobkin JF; Butler VP; Saha JR
Clin Pharmacol Ther; 1983 Dec; 34(6):738-43. PubMed ID: 6641088
[TBL] [Abstract][Full Text] [Related]
20. Effect of metoclopramide on digoxin absorption from tablets and capsules.
Johnson BF; Bustrack JA; Urbach DR; Hull JH; Marwaha R
Clin Pharmacol Ther; 1984 Dec; 36(6):724-30. PubMed ID: 6499354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
